age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
71.69299
|
male
| 0
| 13
|
Colon Cancer
|
Cancer
| 1
| 18
|
>$50k
| 9
| 30,518
| null | null | 26
|
white
| 16.5
| 16
| 0.78894
| 0.555908
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 13
| 112
| 11.398438
| 135
| 31
| 38.29688
| 145
| 3.099609
| 1.299805
| 0.799927
| 135
| 7.399414
| 133
| 12
| 1,220
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 348
| 0
|
73.28699
|
male
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| 14
| null | 0
| 10,775
| null | null | 12
|
white
| 15.898438
| 4
| 0.816895
| 0.605957
| 1
| 0
| 0
|
metastatic
| 0.6
| 0.4
|
no dnr
| 6
| 118
| 8.298828
| 135
| 38
| 35.5
| 226.65625
| 2.399902
| 0.5
| 0.699951
| 128
| 7.319336
| 103
| 10
| 3,730
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 348
| 0
|
70.461
|
male
| 0
| 15
|
Lung Cancer
|
Cancer
| 2
| null | null | 0
| 15,315
| null | null | 9.333328
|
white
| 35.695313
| 39
| 0.189972
| 0.015999
| 1
| 0
| 0
|
metastatic
| 0.3
| 0.2
|
dnr after sadm
| 2
| 108
| 10.599609
| 65
| 16
| 38.09375
| null | null | null | 0.699951
| 138
| 7.429688
| 99
| 5
| 4,280
| 0
| 0
|
adl>=4 (>=5 if sur)
| 0
| 347
| 0
|
69.74896
|
female
| 1
| 29
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
| null | 0
| 213,137
| null | null | 45.5
|
white
| 26.796875
| 46
| 0.60791
| 0.501953
| 10
| 0
| 0
|
yes
| 0.5
| 0.5
|
dnr after sadm
| 28
| 50
| 3.199707
| 145
| 36
| 38.5
| 56.46875
| 2
| 0.899902
| 1.199951
| 142
| 7.25
| 94
| 11
| 1,696
| null | null |
<2 mo. follow-up
| 2.077637
| 29
| 1
|
51.13199
|
male
| 0
| 7
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 0
|
under $11k
| 0
| 24,871
| null | null | 16.5
|
white
| 26.597656
| 34
| 0.613892
| 0.507935
| 4
| 0
| 0
|
yes
| null | null |
no dnr
| 7
| 103
| 7.799805
| 66
| 26
| 36.69531
| null | null | null | 0.699951
| 139
| null | 237
| 24
| 1,800
| null | 6
|
adl>=4 (>=5 if sur)
| 6
| 347
| 0
|
56.70898
|
male
| 1
| 43
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 9
|
$11-$25k
| 0
| 204,861
| null | null | 30
|
white
| 28
| 26
| 0.787964
| 0.660889
| 1
| 0
| 0
|
no
| 0.9
| 0.7
|
dnr after sadm
| 43
| 115
| 6.5
| 101
| 28
| 36.79688
| 177.5
| 2.599609
| 0.899902
| 0.899902
| 145
| 7.449219
| 87
| 21
| 1,700
| 0
| 0
|
<2 mo. follow-up
| 0
| 43
| 1
|
58.03998
|
male
| 0
| 8
|
Colon Cancer
|
Cancer
| 1
| 12
| null | 0
| 15,249
| null | null | 11.5
|
black
| 16.097656
| 21
| 0.839966
| 0.649902
| 1
| 0
| 0
|
metastatic
| 0.6
| 0.3
|
no dnr
| 8
| 83
| 7.799805
| 75
| 18
| 36.79688
| 304
| null | null | 0.899902
| 143
| 7.40918
| 125
| 23
| null | 3
| 1
|
no(M2 and SIP pres)
| 1
| 141
| 1
|
26.44199
|
male
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
|
under $11k
| 0
| 59,332
| null | null | 15
|
black
| 26.296875
| 35
| 0.849976
| 0.797974
| 10
| 0
| 0
|
no
| 0.8
| 0.75
|
no dnr
| 19
| 118
| 11.398438
| 75
| 8
| 36
| 316.625
| 1.899902
| 5.199219
| 1.299805
| 134
| 7.359375
| 176
| 25
| 1,325
| null | null |
no(M2 and SIP pres)
| 2.490723
| 346
| 0
|
45.71399
|
female
| 0
| 6
|
Colon Cancer
|
Cancer
| 2
| 12
|
under $11k
| 0
| 10,864
| null | null | 11
|
black
| 9.099609
| 6
| 0.917969
| 0.80896
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 6
| 118
| 11
| 145
| 24
| 35.89844
| 162.5
| null | 0.5
| 0.699951
| 135
| 7.439453
| 264
| 19
| 1,775
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 345
| 0
|
65.89697
|
male
| 0
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 37
| 67,982
| null | null | 32.666657
|
white
| 63.5
| 51
| 0
| 0
| 3
| 0
| 0
|
no
| 0.4
| 0.2
|
no dnr
| 18
| 111
| 8.5
| 66
| 20
| 38.09375
| null | 4.199219
| 0.699951
| 0.799927
| 139
| null | 95
| 18
| null | null | null |
no(M2 and SIP pres)
| 1.852539
| 295
| 1
|
42.28598
|
male
| 0
| 32
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 10
| null | 9
| 48,077
| null | null | 7.75
|
black
| 32.796875
| 37
| 0.360962
| 0.243988
| 2
| 0
| 0
|
metastatic
| 0.05
| 0
|
dnr after sadm
| 6
| 65
| 20
| 65
| 10
| 38.69531
| 191.40625
| 1.799805
| 3.799805
| 1.899902
| 144
| 7.419922
| 247
| 68
| 3,920
| null | 1
|
<2 mo. follow-up
| 1
| 39
| 1
|
47.33197
|
male
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 11
|
$25-$50k
| 0
| 24,074
| null | null | 19
|
white
| 19.796875
| 15
| 0.897949
| 0.860962
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 8
| 90
| 10.599609
| 105
| 12
| 36.39844
| 195.21875
| 3.299805
| 0.299988
| 0.899902
| 142
| 7.269531
| 110
| 20
| 860
| 0
| 0
|
<2 mo. follow-up
| 0
| 26
| 1
|
67.56995
|
male
| 0
| 20
|
Colon Cancer
|
Cancer
| 1
| null |
>$50k
| 0
| 21,601
| null | null | 8
|
white
| 16.199219
| 11
| 0.822998
| 0.61792
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 20
| 45
| 11.5
| 115
| 13
| 39.19531
| 124.4375
| 2.799805
| null | 0.899902
| 134
| 7.469727
| 141
| 18
| 3,810
| 0
| 0
|
<2 mo. follow-up
| 0
| 55
| 1
|
46.92697
|
male
| 1
| 8
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 16
|
>$50k
| 37
| 61,115
| null | null | 33.5
|
white
| 24.597656
| 44
| 0.362976
| 0.245972
| 13
| 0
| 0
|
metastatic
| null | null |
no dnr
| 8
| 72
| 6.799805
| 125
| 8
| 38.79688
| 230
| 2.5
| null | 1
| 137
| 7.359375
| 89
| 6
| 1,910
| null | null |
<2 mo. follow-up
| 2.751953
| 8
| 1
|
83.10699
|
female
| 1
| 35
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 4
|
under $11k
| 26
| 141,681
| null | null | 36
|
black
| 34.59375
| 51
| 0.164978
| 0.081985
| 12
| 0
| 0
|
yes
| 0.6
| 0.6
|
dnr after sadm
| 10
| 99
| 9.898438
| 76
| 20
| 36.39844
| 332
| null | null | 0.899902
| 136
| 7.399414
| 131
| 21
| 650
| null | 2
|
<2 mo. follow-up
| 2
| 35
| 1
|
61.26999
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 2
| 10
|
$25-$50k
| 0
| 3,754
| 2,838.4238
| 800.45996
| 18
|
white
| 21.898438
| 26
| 0.60791
| 0.291992
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.8
|
no dnr
| 6
| 73
| 5.799805
| 100
| 28
| 35.39844
| null | null | null | 0.799927
| 134
| null | null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 377
| 1
|
51.836
|
female
| 0
| 8
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 5,572
| 4,188.9023
| 1,291.21973
| 7.5
|
white
| 15.898438
| 15
| 0.876953
| 0.795898
| 1
| 0
| 0
|
no
| 0.75
| 0.5
|
no dnr
| 8
| 93
| 3.5
| 80
| 26
| 36.39844
| 369
| 3
| 0.299988
| 0.699951
| 138
| 7.339844
| null | null | null | 1
| 0
|
SIP>=30
| 0
| 2,029
| 0
|
30.04799
|
female
| 0
| 36
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 15
|
under $11k
| 44
| 40,193
| 30,074.125
| 10,792.5156
| 30.25
|
white
| 22.398438
| 20
| 0.823975
| 0.764893
| 2
| 0
| 0
|
no
| 0.75
| 0.5
|
no dnr
| 36
| 68
| 8.898438
| 116
| 7
| 36
| 246.46875
| 2.699707
| 0.5
| 0.5
| 135
| 7.449219
| null | null | null | null | 7
|
adl>=4 (>=5 if sur)
| 7
| 540
| 1
|
56.88397
|
female
| 0
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
$11-$25k
| 9
| 38,938
| 30,539.2812
| 10,389.9453
| 36.333313
|
white
| 32.195313
| 49
| 0.571899
| 0.460999
| 2
| 0
| 0
|
yes
| 0.5
| 0.5
|
no dnr
| 18
| 137
| 10.298828
| 157
| 13
| 38.09375
| 88
| 2.599609
| 1.299805
| 0.599976
| 134
| 7.429688
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 2,026
| 0
|
49.20499
|
female
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 10
|
under $11k
| 0
| 5,771
| 4,279.543
| 1,743.22949
| 7.5
|
other
| 25.898438
| 29
| 0.844971
| 0.744995
| 1
| 1
| 0
|
no
| 0.1
| 0.001
|
no dnr
| 7
| 67
| 11.199219
| 104
| 26
| 35.79688
| 391.375
| 3.099609
| 1.5
| 0.899902
| 133
| 7.489258
| null | null | null | 1
| 5
|
<2 mo. follow-up
| 5
| 24
| 1
|
34.98398
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 11
|
$11-$25k
| 0
| 6,339
| 4,722.0547
| 1,178.40918
| 15
|
black
| 18.796875
| 31
| 0.932983
| 0.885986
| 1
| 1
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 5
| 73
| 10.199219
| 105
| 32
| 36.59375
| 409.5
| 3.599609
| 0.399963
| 1.299805
| 136
| 7.419922
| null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 31
| 1
|
64.64899
|
male
| 1
| 4
|
Coma
|
Coma
| 4
| null | null | 100
| 11,802
| 8,355.5938
| 4,095.76953
| 41
|
white
| 31.796875
| 38
| 0.014
| 0.004999
| 3
| 0
| 0
|
yes
| 0
| 0
|
dnr after sadm
| 4
| 57
| 33.59375
| 103
| 12
| 39.59375
| 135
| null | null | 2.199707
| 138
| 7.449219
| null | null | null | null | null |
<2 mo. follow-up
| 3.930176
| 4
| 1
|
40.44397
|
male
| 0
| 16
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4
| 12
|
$11-$25k
| 0
| 11,137
| 8,525.7734
| 2,284.03906
| 8
|
white
| 21.398438
| 36
| 0.863892
| 0.773926
| 1
| 0
| 0
|
no
| 0.9
| 0.7
|
no dnr
| 16
| 96
| 8.099609
| 84
| 20
| 39
| null | 1.899902
| 8.798828
| 0.599976
| 135
| null | null | null | null | 1
| 1
|
no(M2 and SIP pres)
| 1
| 325
| 1
|
40.55899
|
female
| 0
| 15
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 6
| 12
|
under $11k
| 0
| 15,201
| 12,027.7031
| 2,170.59961
| 15
|
black
| 23.398438
| 47
| 0.829956
| 0.721924
| 2
| 0
| 0
|
no
| 0.8
| 0.5
|
no dnr
| 15
| 145
| 5.599609
| 82
| 30
| 36
| 336.0625
| 2.899902
| 3.099609
| 8.398438
| 135
| 7.399414
| null | null | null | 0
| 0
|
SIP>=30
| 0
| 586
| 1
|
42.71597
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 6
|
under $11k
| 0
| 4,538
| 3,398.3379
| 1,333.5293
| 14
|
white
| 22.796875
| 15
| 0.891968
| 0.81897
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 6
| 97
| 11.398438
| 115
| 22
| 36
| 457.125
| 3.599609
| 0.799927
| 1.199951
| 131
| 7.40918
| null | null | null | 5
| 5
|
adl>=4 (>=5 if sur)
| 5
| 791
| 1
|
30.407
|
male
| 0
| 27
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 138,207
| 98,951.75
| 55,267.5
| 41.75
|
black
| 42.898438
| 83
| 0.131989
| 0.059998
| 43
| 0
| 0
|
yes
| 0.3
| 0.1
|
no dnr
| 27
| 107
| 0.319946
| 176
| 32
| 39.59375
| 147.125
| 3.799805
| 2.099609
| 3.099609
| 135
| 7.379883
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 230
| 1
|
67.409
|
male
| 0
| 8
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 5,608
| 4,262.5117
| 1,240.75977
| 7.5
|
black
| 31.398438
| 51
| 0.429993
| 0.309998
| 1
| 0
| 0
|
metastatic
| 0.1
| 0.001
|
dnr after sadm
| 2
| 97
| 17.898438
| 114
| 36
| 36.29688
| 430.4375
| 2.699707
| 1.799805
| 2.299805
| 130
| 7.209961
| null | null | null | null | null |
<2 mo. follow-up
| 3.778809
| 15
| 1
|
62.49698
|
female
| 1
| 79
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5
| 8
| null | 0
| 151,172
| 113,714.812
| 36,978
| 31
|
white
| 32.398438
| 47
| 0.482971
| 0.36499
| 23
| 1
| 0
|
yes
| 0.25
| 0.2
|
dnr after sadm
| 22
| 114
| 17.597656
| 68
| 32
| 36.5
| 85.625
| null | null | 2.199707
| 133
| 7.429688
| null | null | null | null | 3
|
SIP>=30
| 3
| 79
| 1
|
44.32898
|
female
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 14
| null | 9
| 21,020
| 16,124.1562
| 6,786.53906
| 50
|
white
| 28.898438
| 48
| 0.784912
| 0.714966
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 7
| 70
| 25.296875
| 111
| 22
| 38.5
| 109.5625
| 2.599609
| 0.399963
| 1.699951
| 133
| 7.389648
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 7
| 1
|
37.84
|
male
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 17
|
under $11k
| 0
| 26,070
| 19,550.6719
| 7,092.08984
| 31.666656
|
white
| 30.898438
| 45
| 0.800903
| 0.734985
| 1
| 1
| 0
|
no
| 0.75
| 0.75
|
no dnr
| 15
| 113
| 9.199219
| 118
| 20
| 35.39844
| 254.53125
| 2
| 6.399414
| 0.899902
| 128
| 7.399414
| null | null | null | null | 0
| null | 0
| 2,019
| 0
|
40.29797
|
female
| 0
| 16
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 14,205
| 10,412.1328
| 4,452.14844
| 12.666664
|
white
| 22.597656
| 35
| 0.851929
| 0.755981
| 1
| 0
| 0
|
no
| 0.8
| 0.5
|
no dnr
| 16
| 61
| 5
| 102
| 20
| 36.69531
| 375.6875
| 4.599609
| 1.899902
| 1.5
| 129
| 7.449219
| null | null | null | 2
| 4
|
SIP>=30
| 4
| 94
| 1
|
79.69299
|
male
| 0
| 40
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
| null | 0
| 109,357
| 78,708.625
| 31,970.1406
| 30
|
white
| 30.5
| 57
| 0.501953
| 0.384949
| 26
| 0
| 0
|
no
| 0.3
| 0.25
|
no dnr
| 40
| 110
| 11
| 127
| 11
| 39.19531
| 305
| 1.899902
| 5.199219
| 2.299805
| 133
| 7.459961
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 174
| 1
|
35.49899
|
female
| 1
| 9
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 18
|
$25-$50k
| 44
| 32,652
| 24,079.4688
| 11,113.3984
| 52
|
white
| 42
| 77
| 0.023998
| 0.006
| 4
| 0
| 0
|
metastatic
| 0.05
| 0.000125
|
no dnr
| 9
| 54
| 3.199707
| 176
| 60
| 40
| 98.59375
| 2.599609
| 1.099854
| 0.899902
| 145
| 7.289062
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 9
| 1
|
77.30896
|
male
| 0
| 18
|
Colon Cancer
|
Cancer
| 1
| 12
|
>$50k
| 0
| 12,567
| 9,706.6719
| 2,523.81836
| 9.333328
|
white
| 15.199219
| 22
| 0.81897
| 0.608887
| 1
| 0
| 0
|
metastatic
| 1
| 0.5
|
no dnr
| 18
| 103
| 7.099609
| 60
| 20
| 36.59375
| null | 3.099609
| 0.799927
| 1.399902
| 133
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 237
| 1
|
67.64099
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 3,671
| 2,911.4199
| 1,238
| 1
|
white
| 18
| 16
| 0.679932
| 0.384949
| 1
| 0
| 0
|
metastatic
| 0.25
| 0.01
|
dnr after sadm
| 1
| 95
| 3.899902
| 92
| 28
| 35.79688
| null | null | null | 1
| 141
| null | null | null | null | 0
| 2
|
<2 mo. follow-up
| 2
| 35
| 1
|
62.56497
|
male
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 3
|
under $11k
| 0
| 2,928
| 2,173.5625
| 929.50977
| 11
|
white
| 14.099609
| 28
| 0.899902
| 0.831909
| 1
| 0
| 0
|
yes
| 0.95
| 0.9
|
no dnr
| 4
| 98
| 7.599609
| 100
| 28
| 36.19531
| 273.75
| 4.099609
| 0.299988
| 1.099854
| 138
| 7.229492
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 2,016
| 0
|
55.66898
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
|
under $11k
| 0
| 3,072
| 2,277.4668
| 1,010.32959
| 13
|
white
| 14.099609
| 19
| 0.927979
| 0.876953
| 1
| 1
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 4
| 75
| 8
| 76
| 22
| 36.29688
| 284.75
| null | 0.5
| 1.199951
| 142
| 7.429688
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 400
| 1
|
64.70099
|
female
| 0
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 30,035
| 23,424.5625
| 10,360.9375
| 25.333328
|
white
| 38.296875
| 57
| 0.333984
| 0.218994
| 1
| 0
| 0
|
metastatic
| 0.4
| 0.2
|
no dnr
| 18
| 72
| 2.699707
| 128
| 28
| 36
| 199.625
| 3
| 1
| 3.199707
| 131
| 7.429688
| null | null | null | null | null | null | 3.917481
| 70
| 1
|
69.37195
|
female
| 1
| 17
|
Lung Cancer
|
Cancer
| 3
| null | null | 0
| 13,583
| 10,518.6953
| 3,508.4082
| 7.333332
|
black
| 30.796875
| 29
| 0.302979
| 0.051994
| 2
| 1
| 0
|
metastatic
| 0.5
| 0.1
|
dnr after sadm
| 4
| 83
| 10.699219
| 110
| 28
| 36.19531
| 466.625
| 2.599609
| 0.599976
| 1.099854
| 138
| 7.389648
| null | null | null | null | null |
<2 mo. follow-up
| 4.43457
| 17
| 1
|
78.35498
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 6
|
under $11k
| 0
| 4,032
| 2,952.9238
| 1,376.08984
| 7
|
white
| 27.597656
| 35
| 0.625
| 0.440979
| 1
| 1
| 0
|
yes
| 0.5
| 0.2
|
dnr after sadm
| 1
| 73
| 15.898438
| 120
| 24
| 36
| null | 3.199707
| 1
| 1.599854
| 132
| null | null | null | null | 6
| 3
|
SIP>=30
| 3
| 291
| 1
|
24.931
|
male
| 0
| 22
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 41,978
| null | null | 34
|
white
| 39.296875
| 39
| 0.709961
| 0.621948
| 1
| 0
| 0
|
no
| 0.99
| 0.99
|
no dnr
| 22
| 51
| 21
| 46
| 10
| 35.69531
| 87.5625
| null | null | 0.5
| 135
| 7.459961
| null | null | null | null | 6
|
SIP>=30
| 6
| 2,014
| 0
|
67.32898
|
female
| 0
| 17
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 10,263
| 8,112.8359
| 1,359.84961
| 7
|
white
| 20.898438
| 37
| 0.843994
| 0.744995
| 1
| 1
| 0
|
no
| 0.6
| 0.6
|
no dnr
| 17
| 60
| 4.599609
| 58
| 20
| 36.19531
| null | null | 0.5
| 2.199707
| 135
| null | null | null | null | null | null | null | 3.324219
| 145
| 1
|
56.35599
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 6,956
| 5,181.9805
| 1,674.44922
| 7
|
white
| 15.599609
| 13
| 0.906982
| 0.842896
| 3
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 79
| 5
| 68
| 16
| 36.39844
| null | null | null | 1
| 134
| null | null | null | null | 2
| null | null | 1.839
| 2,012
| 0
|
28.435
|
male
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
|
under $11k
| 0
| 28,546
| 21,811.0938
| 7,453.73828
| 26
|
white
| 20.699219
| 23
| 0.911987
| 0.879883
| 3
| 1
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 19
| 135
| 8.298828
| 126
| 10
| 36.69531
| 200
| 3.299805
| 0.5
| 0.699951
| 137
| 7.429688
| null | null | null | null | 6
|
no(M2 and SIP pres)
| 6
| 2,011
| 0
|
44.74698
|
female
| 1
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 0
| 62,724
| 44,182.9062
| 27,231.3438
| 54.5
|
white
| 35.695313
| 56
| 0.631958
| 0.529907
| 5
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 13
| 70
| 19
| 149
| 27
| 39.69531
| 75.70312
| 2.299805
| 1.599854
| 1.599854
| 147
| 7.449219
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 13
| 1
|
68.90094
|
male
| 0
| 14
|
Colon Cancer
|
Cancer
| 1
| 10
|
under $11k
| 0
| 51,678
| 39,554.6562
| 16,607.25
| 21.666656
|
white
| 37.5
| 23
| 0.194977
| 0.017998
| 42
| 0
| 0
|
metastatic
| 0.75
| 0.5
|
no dnr
| 14
| 73
| 4.899414
| 94
| 20
| 36.59375
| null | 2
| 1.099854
| 0.599976
| 129
| null | null | null | null | 1
| 6
|
<2 mo. follow-up
| 6
| 21
| 1
|
68.48199
|
male
| 0
| 22
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
$11-$25k
| 0
| 48,631
| 36,397.8125
| 18,265.7344
| 32
|
white
| 22.898438
| 40
| 0.702881
| 0.612915
| 10
| 0
| 0
|
yes
| 0.9
| 0.9
|
no dnr
| 22
| 53
| 13.398438
| 71
| 10
| 36.5
| 262.9375
| 1.899902
| 0.199982
| 1.699951
| 135
| 7.399414
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 2,010
| 0
|
60.52298
|
male
| 1
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 6
| null | 55
| 25,975
| 20,341.9688
| 5,722.01953
| 37.5
|
white
| 18.597656
| 30
| 0.756958
| 0.678955
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 11
| 124
| 7
| 115
| 25
| 38.19531
| 304
| 2.799805
| 0.5
| 0.899902
| 135
| 7.459961
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 11
| 1
|
28.55899
|
female
| 1
| 138
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
|
under $11k
| 61
| 94,804
| 197,694
| 78,501.1875
| 44.25
|
black
| 23.5
| 30
| 0.698975
| 0.608887
| 52
| 0
| 0
|
no
| 1
| 0.5
|
dnr after sadm
| 62
| 78
| 33.09375
| 127
| 36
| 38.39844
| 212.5
| 2.799805
| 0.299988
| 0.699951
| 142
| 7.469727
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 138
| 1
|
71.93195
|
male
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
|
$11-$25k
| 26
| 20,133
| 13,816.5078
| 8,076.78906
| 59
|
white
| 46
| 68
| 0.118988
| 0.051994
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 6
| 36
| 17
| 187
| 14
| 37.59375
| 103.1875
| 3.299805
| 1.099854
| 1.699951
| 142
| 7.419922
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 8
| 1
|
61.78497
|
female
| 0
| 37
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
|
$11-$25k
| 41
| 42,011
| 36,107.4062
| 13,650.8047
| 36
|
white
| 35.695313
| 37
| 0.391968
| 0.272949
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
no dnr
| 37
| 44
| 10.898438
| 116
| 40
| 37.79688
| 210.4375
| 3
| 0.899902
| 0.5
| 135
| 7.519531
| null | null | null | null | 6
| null | 6
| 2,007
| 0
|
19.82999
|
male
| 0
| 47
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 11
|
under $11k
| 0
| 88,468
| 66,124.5
| 30,963.5
| 28
|
white
| 27.296875
| 58
| 0.859985
| 0.810913
| 8
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 47
| 73
| 31.5
| 111
| 43
| 38.59375
| 240
| 1.799805
| 4.699219
| 1.599854
| 135
| 7.419922
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 2,005
| 0
|
41.78
|
female
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null |
under $11k
| 37
| 23,366
| 16,430.8281
| 9,346.36719
| 54
|
white
| 32.398438
| 67
| 0.542969
| 0.428955
| 10
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 5
| 61
| 29.199219
| 115
| 12
| 40.5
| 182.59375
| 0.799927
| 2.399902
| 2.699707
| 133
| 7.459961
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 5
| 1
|
32.81
|
male
| 1
| 8
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4
| null | null | 0
| 22,651
| null | null | 55.5
|
other
| 26.597656
| 32
| 0.837891
| 0.734985
| 1
| 0
| 0
|
no
| 0.6
| 0.4
|
no dnr
| 8
| 123
| 9.898438
| 136
| 30
| 35.89844
| null | 2.5
| 2.699707
| 0.599976
| 137
| null | null | null | null | null | null |
<2 mo. follow-up
| 3.158203
| 8
| 1
|
71.67999
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 11
|
under $11k
| 0
| 4,250
| 3,164.7832
| 1,135.85938
| 7
|
white
| 20.597656
| 33
| 0.794922
| 0.669922
| 1
| 0
| 0
|
yes
| 0.8
| 0.6
|
no dnr
| 6
| 77
| 7.5
| 136
| 30
| 38.39844
| null | 3.399902
| 0.899902
| 1
| 134
| null | null | null | null | 1
| 2
|
SIP>=30
| 2
| 295
| 1
|
69.06494
|
female
| 0
| 35
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
|
under $11k
| 0
| 51,892
| 38,072
| 11,698.5391
| 23.5
|
white
| 36.09375
| 43
| 0.54895
| 0.350952
| 1
| 0
| 0
|
no
| 0.7
| 0.5
|
no dnr
| 35
| 63
| 7.699219
| 52
| 18
| 35.29688
| 257.75
| 2.699707
| 5
| 1.799805
| 121
| 7.449219
| null | null | null | null | null | null | 3.983887
| 316
| 1
|
47.31
|
male
| 0
| 4
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 11
|
under $11k
| 0
| 2,390
| 1,865.4102
| 616.91992
| 10
|
white
| 28.796875
| 31
| 0.720947
| 0.564941
| 1
| 0
| 0
|
no
| 0.25
| 0.1
|
no dnr
| 4
| 63
| 10.898438
| 70
| 20
| 36
| 351.375
| 2.699707
| 1.5
| 2.299805
| 123
| 7.359375
| null | null | null | 4
| 4
|
adl>=4 (>=5 if sur)
| 4
| 75
| 1
|
44.34497
|
male
| 0
| 4
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 5
| 12
|
under $11k
| 0
| 3,131
| 2,288.5469
| 1,054.86914
| 3
|
white
| 25.199219
| 33
| 0.799927
| 0.677979
| 1
| 0
| 0
|
no
| 0.9
| 0.5
|
no dnr
| 4
| 65
| 9.599609
| 110
| 22
| 36.79688
| null | 2.199707
| 5.099609
| 1
| 129
| null | null | null | null | 2
| 3
|
no(M2 and SIP pres)
| 3
| 2,002
| 0
|
61.28998
|
male
| 0
| 14
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 9
|
under $11k
| 0
| 11,336
| 8,405.0625
| 3,265.48828
| 13
|
black
| 37.59375
| 74
| 0.586914
| 0.394958
| 1
| 0
| 0
|
no
| 0.8
| 0.4
|
no dnr
| 14
| 79
| 7.599609
| 110
| 36
| 35.79688
| 59.58594
| 3.699707
| 3.5
| 1.799805
| 144
| 7.199219
| null | null | null | 1
| null |
no(M2 and SIP pres)
| 1.1669
| 92
| 1
|
71.52899
|
female
| 0
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 9
| null | 0
| 7,352
| 5,145.6758
| 2,710.29883
| 36
|
black
| 29.5
| 59
| 0.684937
| 0.591919
| 1
| 0
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 6
| 157
| 14.099609
| 155
| 34
| 36.79688
| 302.625
| 3.299805
| 1
| 4.299805
| 141
| 7.379883
| null | null | null | null | null |
adl>=4 (>=5 if sur)
| 2.599121
| 62
| 1
|
55.159
|
female
| 1
| 3
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 8
|
$11-$25k
| 100
| 8,871
| 6,550.4883
| 2,963.44922
| 17
|
black
| 69.6875
| 66
| 0
| 0
| 8
| 0
| 0
|
metastatic
| 0
| 0
|
dnr after sadm
| 2
| 0
| 21.5
| 0
| 0
| 38.19531
| 311.875
| null | null | 0.599976
| 145
| 7.40918
| null | null | null | null | null |
<2 mo. follow-up
| 3.336426
| 3
| 1
|
58.431
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 7
| 12
|
under $11k
| 0
| 8,990
| 6,529.2305
| 2,535.00977
| 23
|
white
| 26.898438
| 43
| 0.79895
| 0.675903
| 1
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 6
| 60
| 16.296875
| 75
| 24
| 37.69531
| 203.65625
| 3.899902
| 0.899902
| 7.199219
| 121
| 7.5
| null | null | null | null | 2
|
SIP>=30
| 2
| 218
| 1
|
68.20496
|
male
| 0
| 9
|
Colon Cancer
|
Cancer
| 3
| 15
|
$25-$50k
| 0
| 6,141
| 4,727.3555
| 1,450.80957
| 7.5
|
white
| 21.898438
| 32
| 0.731934
| 0.460999
| 1
| 1
| 0
|
metastatic
| 0.9
| 0.7
|
no dnr
| 9
| 75
| 10.5
| 56
| 16
| 36.39844
| null | null | null | 2.099609
| 135
| null | null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 399
| 1
|
31.95299
|
female
| 1
| 91
|
Coma
|
Coma
| 1
| 10
|
under $11k
| 100
| 119,299
| 89,641.0625
| 28,174.3281
| 29.5
|
hispanic
| 27.097656
| 30
| 0.452942
| 0.379944
| 1
| 0
| 0
|
no
| 0.65
| 0.6
|
dnr after sadm
| 46
| 69
| 15.199219
| 126
| 24
| 38.09375
| 132
| 2.599609
| 3.299805
| 1.099854
| 143
| 7.349609
| null | null | null | null | 7
|
adl>=4 (>=5 if sur)
| 7
| 91
| 1
|
36.62698
|
male
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| null | null | 0
| 8,429
| 6,005.6445
| 3,148.72852
| 10
|
white
| 21.097656
| 22
| 0.906982
| 0.872925
| 1
| 1
| 1
|
no
| 0.95
| 0.95
|
no dnr
| 7
| 68
| 6.5
| 68
| 20
| 35.79688
| 514.25
| 2.799805
| 0.399963
| 0.599976
| 130
| 7.429688
| null | null | null | null | null | null | 5.543945
| 1,338
| 1
|
46.05298
|
female
| 1
| 4
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 3,829
| 2,781.1406
| 1,602.76953
| 21
|
black
| 24.199219
| 24
| 0.596924
| 0.277954
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 4
| 108
| 10.398438
| 122
| 28
| 37.5
| null | 3.099609
| 0.5
| 1
| 141
| null | null | null | null | null | null |
<2 mo. follow-up
| 2.757324
| 4
| 1
|
49.26797
|
female
| 1
| 11
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 10,142
| 7,426.9219
| 3,350.51953
| 19.5
|
white
| 42.195313
| 73
| 0.15799
| 0.076996
| 1
| 1
| 0
|
metastatic
| null | null |
dnr after sadm
| 2
| 47
| 10.898438
| 51
| 44
| 34.09375
| 251.65625
| 2.599609
| 1.899902
| 2.399902
| 133
| 7.229492
| null | null | null | null | null |
<2 mo. follow-up
| 4.105469
| 11
| 1
|
64.88196
|
male
| 1
| 16
|
Colon Cancer
|
Cancer
| 1
| 10
|
$11-$25k
| 0
| 14,860
| 11,180.2422
| 4,777.23828
| 20.333328
|
white
| 42.296875
| 32
| 0.20697
| 0.019997
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 13
| 73
| 13.099609
| 75
| 26
| 35
| null | 1.599854
| 1.099854
| 0.5
| 133
| null | null | null | null | 4
| null |
<2 mo. follow-up
| 3.183199
| 16
| 1
|
87.64697
|
female
| 0
| 12
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 8
|
under $11k
| 0
| 8,111
| 6,287.2188
| 1,623.80957
| 15.5
|
white
| 29.398438
| 40
| 0.448975
| 0.328979
| 1
| 0
| 0
|
metastatic
| 0.2
| 0
|
dnr before sadm
| 0
| 104
| 10.599609
| 109
| 28
| 36.5
| 159.15625
| 2.699707
| 0.399963
| 2
| 133
| 7.379883
| null | null | null | 0
| 6
|
<2 mo. follow-up
| 6
| 28
| 1
|
50.46997
|
female
| 0
| 6
|
MOSF w/Malig
|
ARF/MOSF
| 4
| 12
|
under $11k
| 0
| 5,985
| 4,367.8477
| 2,013.09961
| 14
|
white
| 25.796875
| 38
| 0.611938
| 0.505981
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.9
|
no dnr
| 6
| 63
| 2.199707
| 90
| 20
| 38.39844
| null | 4.099609
| 4
| 1.799805
| 136
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,254
| 1
|
67.19495
|
male
| 0
| 22
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 161,730
| 125,781.938
| 34,366.0625
| 24.666656
|
black
| 27.199219
| 33
| 0.650879
| 0.55188
| 53
| 0
| 0
|
no
| 0.4
| 0.3
|
no dnr
| 22
| 76
| 20.296875
| 150
| 9
| 35.79688
| 300
| 2.799805
| 0.5
| 0.799927
| 129
| 7.439453
| null | null | null | 1
| 6
|
adl>=4 (>=5 if sur)
| 6
| 661
| 1
|
78.724
|
female
| 0
| 61
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 9
| 83,082
| 64,754.0625
| 16,091.625
| 33
|
white
| 24.796875
| 42
| 0.711914
| 0.552979
| 1
| 0
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 61
| 72
| 7.199219
| 63
| 29
| 36.39844
| 168.15625
| 3.099609
| 0.399963
| 0.699951
| 136
| 7.419922
| null | null | null | null | 6
|
no(M2 and SIP pres)
| 6
| 1,994
| 0
|
48.45999
|
female
| 0
| 17
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4
| null | null | 0
| 18,182
| 13,137.2734
| 6,702.25781
| 11.333328
|
white
| 21.398438
| 18
| 0.829956
| 0.7229
| 1
| 0
| 0
|
no
| 0.8
| 0.5
|
no dnr
| 17
| 91
| 6.5
| 105
| 20
| 36.5
| 338.0625
| 2.799805
| 4.599609
| 1
| 134
| 7.429688
| null | null | null | 1
| null |
SIP>=30
| 1.1669
| 167
| 1
|
55.66599
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
|
under $11k
| 0
| 4,172
| 3,183.1231
| 1,263.95996
| 10
|
black
| 17.5
| 18
| 0.905884
| 0.840942
| 1
| 1
| 0
|
no
| 1
| 1
|
no dnr
| 6
| 113
| 6.599609
| 70
| 23
| 35.79688
| null | 3.099609
| 0.299988
| 1.199951
| 134
| null | null | null | null | 1
| 2
|
no(M2 and SIP pres)
| 2
| 1,993
| 0
|
57.35797
|
female
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 9
|
under $11k
| 0
| 6,204
| 4,697.7812
| 1,339.28906
| 15
|
white
| 18.898438
| 19
| 0.902954
| 0.836914
| 1
| 0
| 0
|
no
| 0.75
| 0.75
|
no dnr
| 9
| 124
| 13
| 96
| 24
| 36.59375
| 232.25
| null | null | 1.399902
| 134
| 7.379883
| null | null | null | 5
| 2
|
SIP>=30
| 2
| 1,814
| 1
|
78.54297
|
male
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 14
|
under $11k
| 0
| 4,418
| 3,298.2129
| 1,180.86914
| 6
|
white
| 33.09375
| 43
| 0.510986
| 0.309998
| 1
| 0
| 0
|
no
| 0.7
| 0.4
|
dnr after sadm
| 1
| 54
| 11
| 55
| 26
| 35.09375
| 101.65625
| 3.699707
| 0.699951
| 1.099854
| 147
| 7.399414
| null | null | null | 3
| null |
<2 mo. follow-up
| 2.511099
| 39
| 1
|
61.142
|
male
| 0
| 17
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 7
|
under $11k
| 0
| 26,263
| 19,732.5938
| 6,635.56641
| 13.666664
|
black
| 27.597656
| 33
| 0.736938
| 0.587891
| 8
| 0
| 0
|
no
| 0.8
| 0.9
|
no dnr
| 17
| 108
| 18.398438
| 116
| 34
| 36.39844
| 163.6875
| 3.399902
| 0.5
| 1.199951
| 132
| 7.399414
| null | null | null | 1
| 0
|
SIP>=30
| 0
| 149
| 1
|
54.43698
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 3,960
| 3,163.5859
| 1,596.58984
| 15
|
black
| 16.796875
| 26
| 0.736938
| 0.468994
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 2
| 68
| 9.599609
| 108
| 28
| 37.79688
| 361.875
| 3.699707
| 1
| 1.399902
| 138
| 7.459961
| null | null | null | null | null | null | 2.402344
| 75
| 1
|
56.23798
|
male
| 0
| 7
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| null |
under $11k
| 0
| 10,796
| 8,250.9375
| 3,585.51953
| 13
|
white
| 20.597656
| 23
| 0.802979
| 0.681885
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 7
| 72
| 15.5
| 52
| 25
| 36.29688
| null | 2.099609
| 1.399902
| 0.899902
| 140
| null | null | null | null | null | 2
|
no(M2 and SIP pres)
| 2
| 1,991
| 0
|
76.64899
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| null |
under $11k
| 0
| 5,597
| 4,162.5547
| 1,534.0293
| 7
|
white
| 14.099609
| 33
| 0.858887
| 0.767944
| 1
| 0
| 0
|
yes
| null | null |
no dnr
| 7
| 103
| 7.199219
| 76
| 25
| 35.69531
| 283.875
| 3.399902
| 0.399963
| 1.099854
| 128
| 7.509766
| null | null | null | null | null | null | 2.806152
| 94
| 1
|
60.00497
|
female
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 9
|
under $11k
| 0
| 6,427
| 4,872.8867
| 1,547.40918
| 7.5
|
black
| 17.296875
| 27
| 0.872925
| 0.78894
| 1
| 1
| 0
|
yes
| 0.9
| 0.6
|
no dnr
| 9
| 105
| 7.799805
| 65
| 15
| 36.5
| 247.59375
| null | null | 1.699951
| 141
| 7.40918
| null | null | null | 0
| 0
|
SIP>=30
| 0
| 1,552
| 1
|
37.89499
|
male
| 1
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 12
|
under $11k
| 0
| 35,796
| 26,760.6719
| 11,480.7266
| 50
|
white
| 38.398438
| 54
| 0.664917
| 0.56897
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 10
| 55
| 13.699219
| 113
| 32
| 38.09375
| 88.10938
| 2.599609
| 3.399902
| 0.599976
| 131
| 7.549805
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 11
| 1
|
54.92999
|
male
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$25-$50k
| 0
| 11,858
| 8,400.3438
| 4,436.59766
| 15
|
white
| 25.398438
| 35
| 0.820923
| 0.760986
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 11
| 71
| 11.599609
| 114
| 34
| 37.69531
| 167.5
| 2.399902
| 1.099854
| 0.699951
| 137
| 7.469727
| null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 1,987
| 0
|
66.51099
|
female
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 5,125
| 3,824.4434
| 1,248.62988
| 6.5
|
black
| 20.199219
| 34
| 0.85498
| 0.761963
| 1
| 0
| 0
|
no
| 0.99
| 0.99
|
no dnr
| 7
| 75
| 5.399414
| 73
| 25
| 35.09375
| 203.96875
| 3.699707
| 0.399963
| 1.199951
| 138
| 7.319336
| null | null | null | 0
| 1
|
SIP>=30
| 1
| 802
| 1
|
61.28998
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 11
|
under $11k
| 0
| 2,292
| 1,767.9736
| 528.97998
| 10
|
white
| 19.097656
| 13
| 0.880981
| 0.800903
| 1
| 0
| 0
|
no
| 1
| 0.9
|
no dnr
| 4
| 73
| 5.399414
| 96
| 24
| 36
| 401.875
| 3.099609
| 0.599976
| 0.899902
| 138
| 7.419922
| null | null | null | 1
| null |
no(M2 and SIP pres)
| 1.1669
| 1,985
| 0
|
61.952
|
female
| 0
| 29
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5
| 11
|
under $11k
| 0
| 37,986
| 28,746.4062
| 10,535.4688
| 31.5
|
black
| 21.097656
| 37
| 0.851929
| 0.800903
| 1
| 1
| 0
|
no
| 0.7
| 0.65
|
no dnr
| 29
| 127
| 9.199219
| 107
| 30
| 37.89844
| 168.75
| 3.099609
| 1
| 1
| 136
| 7.469727
| null | null | null | null | 5
|
adl>=4 (>=5 if sur)
| 5
| 72
| 1
|
69.15295
|
female
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 12
|
under $11k
| 0
| 3,073
| 2,255.6621
| 987.70996
| 11
|
white
| 16.097656
| 34
| 0.884888
| 0.807983
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 4
| 61
| 3.5
| 64
| 32
| 36.29688
| 204.75
| 4
| 0.599976
| 0.699951
| 137
| 7.40918
| null | null | null | 1
| 1
|
no(M2 and SIP pres)
| 1
| 1,984
| 0
|
73.53296
|
female
| 1
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 0
| 251,017
| 187,147.5
| 75,303.3125
| 42.333313
|
white
| 23.097656
| 28
| 0.702881
| 0.612915
| 94
| 0
| 0
|
no
| 0.7
| 0.5
|
dnr after sadm
| 19
| 125
| 18.898438
| 118
| 9
| 36.69531
| 239.3125
| 1.899902
| 0.799927
| 0.799927
| 131
| 7.439453
| null | null | null | 3
| 0
|
<2 mo. follow-up
| 0
| 20
| 1
|
64.73395
|
male
| 0
| 12
|
Colon Cancer
|
Cancer
| 1
| 11
|
$11-$25k
| 0
| 9,608
| 7,434.043
| 3,044.12891
| 12
|
white
| 21.699219
| 31
| 0.744995
| 0.482971
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.5
|
no dnr
| 12
| 110
| 7.199219
| 60
| 20
| 36
| null | null | 0.399963
| 6.699219
| 141
| null | null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 35
| 1
|
72.14496
|
female
| 1
| 5
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 4,432
| 3,190.625
| 1,561.61914
| 24
|
white
| 26
| 24
| 0.570923
| 0.459961
| 1
| 0
| 0
|
metastatic
| 0.1
| 0.001
|
dnr before sadm
| -1
| 115
| 9.398438
| 106
| 30
| 36
| 418.5625
| 2.599609
| 0.199982
| 0.699951
| 126
| 7.209961
| null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 5
| 1
|
67.59998
|
female
| 0
| 45
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null |
under $11k
| 0
| 61,206
| 45,495.75
| 15,383.1328
| 26.25
|
black
| 40.296875
| 86
| 0.309998
| 0.197998
| 15
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 23
| 63
| 15.099609
| 140
| 40
| 35.39844
| 126.6875
| 1.899902
| 0.5
| 2.299805
| 129
| 7.449219
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,979
| 0
|
51.33698
|
female
| 0
| 42
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 66,895
| 50,142.4688
| 18,910.1562
| 17.5
|
black
| 20.097656
| 25
| 0.862915
| 0.772949
| 10
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 42
| 68
| 8.099609
| 76
| 22
| 35.5
| null | 3.099609
| 0.399963
| 1.5
| 135
| null | null | null | null | 0
| null | null | 0.4948
| 181
| 1
|
56.14798
|
male
| 0
| 31
|
MOSF w/Malig
|
ARF/MOSF
| 3
| 12
|
$25-$50k
| 0
| 54,778
| 39,451.75
| 17,885.5156
| 26.25
|
white
| 31.898438
| 43
| 0.392944
| 0.273987
| 25
| 1
| 0
|
yes
| 0.7
| 0.3
|
no dnr
| 31
| 63
| 0.099991
| 120
| 24
| 38.5
| null | 3.099609
| 0.599976
| 0.899902
| 126
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 374
| 1
|
71.82196
|
male
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 0
|
under $11k
| 0
| 7,363
| 5,533.4102
| 1,675.3291
| 6
|
black
| 14.599609
| 23
| 0.86792
| 0.780884
| 1
| 0
| 0
|
yes
| 0.95
| 0.9
|
no dnr
| 9
| 60
| 5.699219
| 64
| 24
| 35.5
| 309.5
| 3.899902
| 0.699951
| 1
| 138
| 7.419922
| null | null | null | 2
| 0
|
no(M2 and SIP pres)
| 0
| 1,977
| 0
|
38.45599
|
male
| 0
| 43
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 62,292
| 48,560.375
| 18,525.4375
| 16.25
|
white
| 26.898438
| 21
| 0.735962
| 0.585938
| 22
| 1
| 0
|
no
| 0.9
| 0.6
|
no dnr
| 43
| 82
| 13
| 122
| 22
| 38
| 403.3125
| 3.299805
| 4.099609
| 0.5
| 131
| 7.449219
| null | null | null | null | 7
|
adl>=4 (>=5 if sur)
| 7
| 1,977
| 0
|
69.51099
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 7
| 9
|
$11-$25k
| 0
| 2,553
| 1,985.8906
| 672.65967
| 6
|
white
| 17.796875
| 25
| 0.800903
| 0.678955
| 1
| 1
| 0
|
metastatic
| 0.99
| 0.95
|
no dnr
| 4
| 73
| 6.399414
| 58
| 20
| 36
| null | 3.399902
| 0.399963
| 1.199951
| 135
| null | null | null | null | 1
| null |
no(M2 and SIP pres)
| 1.1669
| 1,976
| 0
|
74.21198
|
female
| 1
| 3
|
MOSF w/Malig
|
ARF/MOSF
| 4
| 8
|
under $11k
| 100
| 8,157
| 6,242.8867
| 2,263.73828
| 34
|
white
| 79.59375
| 75
| 0
| 0
| 3
| 1
| 0
|
metastatic
| 0.05
| 0.000125
|
no dnr
| 3
| 0
| 2.799805
| 0
| 0
| 39
| 99.15625
| 2.599609
| 1.199951
| 1
| 137
| 7.289062
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 3
| 1
|
64.81299
|
female
| 0
| 12
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 9
|
under $11k
| 0
| 9,217
| 7,024.7773
| 2,455.71875
| 10.5
|
hispanic
| 19.699219
| 30
| 0.865967
| 0.777954
| 1
| 1
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 12
| 58
| 8.699219
| 44
| 16
| 36.09375
| null | 3.599609
| 1.099854
| 1
| 140
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 488
| 1
|
58.21997
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 2
| 14
|
under $11k
| 0
| 4,723
| 3,596.1172
| 1,580.91992
| 10
|
white
| 6.199219
| 9
| 0.873901
| 0.716919
| 1
| 0
| 0
|
metastatic
| 1
| 1
|
no dnr
| 6
| 87
| 11.199219
| 72
| 16
| 36.59375
| 238.09375
| 4.299805
| null | 1
| 140
| 7.40918
| null | null | null | 0
| null | null | 0.4948
| 1,976
| 0
|
46.98398
|
female
| 1
| 4
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
| null | 100
| 2,358
| 1,865.3467
| 470.62988
| 24
|
white
| 29.296875
| 41
| 0.122986
| 0.054993
| 1
| 0
| 0
|
yes
| 0
| 0
|
dnr before sadm
| -1
| 79
| 2.199707
| 124
| 36
| 38.79688
| null | 2.699707
| 0.799927
| 1.099854
| 130
| null | null | null | null | null | 4
|
<2 mo. follow-up
| 4
| 4
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.